Duloxetine Capsule, Delayed Release
Product Images NDC 49252-007

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 49252-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Inventia Healthcare Limited., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D633baad 41fe 491c A563 517d726028c6 01

FDA Label Image

D633baad 41fe 491c A563 517d726028c6 02

FDA Label Image

D633baad 41fe 491c A563 517d726028c6 03

This appears to be a graph showing the proportion of patients with relapse over time (measured in days) following randomization. The y-axis shows the proportion of patients (ranging from 0% to 8%) and the x-axis shows the time in days. However, without more context or information it is difficult to provide a more detailed or accurate description.*

FDA Label Image

D633baad 41fe 491c A563 517d726028c6 04

FDA Label Image

D633baad 41fe 491c A563 517d726028c6 05

FDA Label Image

D633baad 41fe 491c A563 517d726028c6 06

This is a graph displaying the percentage of patients who experienced an improvement in pain from baseline (BOCF) after taking either a placebo or Durene in doses of 60mg or 120mg once a day. The horizontal axis shows the percentage of improvement in pain, while the vertical axis includes the medicines and the scale of the graph. There are no non-English characters.*

FDA Label Image

D633baad 41fe 491c A563 517d726028c6 07

FDA Label Image

D633baad 41fe 491c A563 517d726028c6 08

This appears to be a graph showing the improvement in pain from baseline for patients taking a placebo and patients taking a medication called DULO at 60/120 mg once daily. The graph shows that the percentage of patients improved by a certain percentage, but the specific improvement percentage is cut off and unrecognizable due to the limitations of .*

FDA Label Image

D633baad 41fe 491c A563 517d726028c6 09

This appears to be a graph showing the percentage of patients who experienced improvement in pain after taking a medication called "Placeto" at different time intervals. The medication is taken once daily and the graph shows the percentage of improvement in pain compared to the baseline (BOCF). The x-axis shows the different time intervals and the y-axis shows the percentage of improvement in pain. However, the text is not entirely readable and some information may be missing, so this description is not 100% certain.*

FDA Label Image

D633baad 41fe 491c A563 517d726028c6 10

This is a graph or table displaying the percentage of patients who experienced improvement in pain intensity. The improvement rate is shown for both placebo and DULO treatments, with doses of 60 and 120 mg taken once daily. The x-axis represents the level of improvement, with values ranging from 50% to 100%. The y-axis shows the range of doses. No further information is available to provide additional context for this data.*

FDA Label Image

D633baad 41fe 491c A563 517d726028c6 11

This is the label of a medication bottle containing 30 capsules of Duloxetine hydrochloride USP. Each capsule has 22.4 mg of the active ingredient, which is equivalent to 20 mg of duloxetine. The medication must be stored in a tightly closed container at 25°C. The label includes the medication code number and the manufacturer's information.*

FDA Label Image

D633baad 41fe 491c A563 517d726028c6 12

FDA Label Image

D633baad 41fe 491c A563 517d726028c6 13

This is a description of a medication in capsule form containing 67.3 mg of duloxetine hydrochloride USP. Each capsule is equivalent to 60 mg of duloxetine. The medication is manufactured by Inventia Healthcare Limited and comes in a bottle with 30 capsules. The recommended dosage can be found in the accompanying literature; it is advised to not use the medication if the inner seal is missing or broken. The capsules are delayed-release and should be stored in a tightly closed container at 25°C. A medication code and Aok Code are also included. There is an unvarnished area on the packaging measuring 45 x 15 mm.*

FDA Label Image

D633baad 41fe 491c A563 517d726028c6 236 2

FDA Label Image

D633baad 41fe 491c A563 517d726028c6 41 1

FDA Label Image

D633baad 41fe 491c A563 517d726028c6 41 2

FDA Label Image

D633baad 41fe 491c A563 517d726028c6 41 3

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.